Table 2.
Ingenuity Pathway Analysis (IPA) demonstrating significantly inhibited cellular functions in angiomyolipoma (AML) cells treated for 24 h with GW9662 compared with control, vehicle‐treated cells
| Function | P‐value | # Molecules |
|---|---|---|
| Cell movement | 2.34E‐21 | 268 |
| Vasculogenesis | 8.93E‐17 | 122 |
| Migration of endothelial cells | 2.54E‐11 | 55 |
| Proliferation of vascular smooth muscle cells | 1.11E‐09 | 32 |
| Organization of cytoskeleton | 1.25E‐09 | 148 |
| Movement of vascular smooth muscle cells | 2.10E‐09 | 26 |
| Organization of cytoplasm | 2.98E‐08 | 152 |
| Cell survival | 1.11E‐07 | 154 |
| Cell transformation | 3.98E‐06 | 60 |
| Remodeling of blood vessel | 6.31E‐06 | 15 |